Delivery 4–6 days
tracked, from the EU
Janoshik report
published
COA
lab results
Retatrutide peptide
Triple-receptor agonist peptide (39 amino acids) · purity spec. >99% HPLC
−20%
First order
€94.90 €75.92
ends 24 December
30-day returns
Changed your mind? Return sealed vials within 30 days for a full refund.
Details in the refund policy.
- Ships to Ireland · 4–6 business daysShips in 1–2 business days · €9.90 shipping
- Discreet packagingplain box · sealed, cold-packed
Research use only. Not for human or veterinary use. Not evaluated by the FDA. Not intended to diagnose, treat, cure or prevent any disease.OXpeptides is not affiliated with Eli Lilly and Company or the TRIUMPH trials. Retatrutide is an investigational compound, not approved for human use in any jurisdiction. Research use only.
€25.10 more for free shipping (from €120 after discounts).
More ways to save — the add-ons, at your plan price
Add GHK-Cu 100 mg · +€38.90
Add Pink Syringes 1 mL 30 pcs · +€26.90
After you order
Order timeline, step by step
Next
Packed
1–2 business days
Sealed vials, cold-packed, the Janoshik report published online.
Then
Shipped
tracked, from the EU
Handed to the carrier. The tracking link lands in your inbox.
Estimated
Delivered
4–6 business days
At your door, in a plain box with nothing on the outside.
If nothing moves for 48 hours, reply to your confirmation e-mail: a person reads it and chases the carrier for you.
Refund policy →No reviews yet. Every review published here will come from a verified order.
OXpeptides vs others
OXpeptidesOthersSpecifications
Retatrutide is supplied as a lyophilized powder in a sealed glass vial labelled with the compound and the net quantity in milligrams; its Janoshik report per size is published on this page. It is offered in 3 sizes: 10 mg (€94.90), 20 mg (€149.90), 30 mg (€199.90). The stated specification is >99% by HPLC; the published Janoshik report reports 99.316%. Tracked shipping from the EU.
Purity spec
>99% HPLC
Temperature
−20 °C, sealed (short term ≤ 4 weeks: 2 to 8 °C)
Shelf life
18 months (lyophilized, sealed)
Keep sealed, protected from light and moisture
In the literature
Retatrutide (LY3437943) is a synthetic 39-amino-acid acylated peptide, a triple agonist of the GIP, glucagon-like peptide and glucagon receptors, supplied as a lyophilized powder in a sealed borosilicate vial.
Described in the literature under the code LY3437943 as a triple agonist of the GIP, glucagon-like peptide and glucagon receptors, characterised in receptor-binding and cellular models. Each size sold here has its own Janoshik Analytical report, published on this page.
Questions about Retatrutide
About OXpeptides
Who we are
OX RESEARCH LTD operates OXpeptides. Company number 17464288 (England and Wales). We supply lyophilized research peptides in sealed glass vials, and one laboratory diluent, to researchers and laboratories.
How we work
Our reports come from Janoshik Analytical, one per size: HPLC purity and mass-spectrometry identity. Each report is published on the product page with its date as soon as the laboratory returns it; a product whose report is not back says so, in those words, rather than borrowing figures from elsewhere. Every vial is crimp-sealed and carries the compound name and the net quantity in milligrams; each report is published with its task number and verification key. Orders ship from the warehouse that serves the delivery address, tracked.
Who we sell to
Researchers and laboratories. Three things we do not do: we publish no quantities, no routes and no schedules anywhere on this site, and support declines those questions; we publish no certificate we do not hold; and we publish no customer review that does not come from a verified order.
The full entity record, the testing method step by step and what the company does not do are on the About page.